Core Insights - FedEx Corporation (FDX) reported strong first-quarter fiscal 2026 results, with earnings and revenues exceeding expectations, showcasing effective strategic initiatives and operational efficiencies [1][9] Financial Performance - Quarterly earnings per share (EPS) were $3.83, surpassing the Zacks Consensus Estimate of $3.65, and reflecting a year-over-year increase of 6.4% [1][9] - Revenues reached $22.2 billion, exceeding the Zacks Consensus Estimate of $21.7 billion and improving by 3% compared to the same quarter last year [2][9] - Operating income increased by 10% to $1.19 billion, with operating margin rising to 5.3% from 5.0% year-over-year, driven by U.S. domestic package revenue strength and cost reductions [3][9] Segment Performance - FedEx Express segment revenues grew by 4% year-over-year to $19.1 billion, supported by higher domestic and international package yields [6] - FedEx Freight revenues declined by 3% year-over-year to $2.25 billion, impacted by lower revenue and higher wage rates [7] Strategic Initiatives - The planned spin-off of FedEx Freight into a new publicly traded company is expected to be completed by June 2026, aiming for a tax-efficient structure for shareholders [5][9] - FedEx anticipates permanent cost reductions of $1 billion from transformation-related savings and plans to invest $4.5 billion in capital expenditures focused on network optimization and efficiency improvements [10][12] Liquidity and Share Repurchase - At the end of the first quarter, FedEx had cash and cash equivalents of $6.16 billion, an increase from $5.50 billion in the previous quarter, and completed $500 million in share repurchases [8]

Core Insights - McKesson's stock slightly outperformed the market following its fourth quarter fiscal 2025 results, gaining 0.5% while the S&P 500 index declined by less than 0.1% [1] Financial Performance - McKesson reported revenue of $90.8 billion for the fourth quarter, representing a 19% increase compared to the same quarter last year [2] - The company's non-GAAP net profit grew by 15% to nearly $1.3 billion, translating to $10.12 per share [2] - Despite strong growth, McKesson's revenue fell short of the consensus analyst estimate of $93.5 billion, and adjusted profitability was below the expected $9.81 per share [3] Strategic Moves - CEO Brian Tyler highlighted the strength of McKesson's core pharmaceutical distribution business and the expansion of its oncology platform as key drivers of strong results [3] - McKesson announced plans to spin off its medical-surgical solutions unit into a new independent company [3] Future Guidance - For fiscal 2026, McKesson provided guidance for adjusted net income per share in the range of $36.75 to $37.55, exceeding the previous estimate of $33.05, with the consensus estimate at $36.83 [4]